Medicines / Intas Pharmaceuticals / Olpaza
OlpazaOlaparib
Olpaza is marketed by Intas Pharmaceuticals. 2 packs on NPPA's price list for July 2026, containing Olaparib.
- Packs listed
- 2
- Lowest MRP
- ₹4,200
- Per unit
- ₹140.00 to ₹193.75
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹4,200Olpaza 100 mg Tablet 30Olaparib Tablet 100 mg · ₹140.00 per tablet
- ₹5,812Olpaza 150 mg Tablet 30Olaparib Tablet 150 mg · ₹193.75 per tablet
The same composition from other brands
Packs with the identical filed composition, form and strength. A different brand is not automatically interchangeable: ask your doctor or pharmacist.
Olaparib Tablet 100 mg
- ₹107.14/tabletRibaxa · 10 tabletDr. Reddys Laboratories · MRP ₹1,071
- ₹134.23/tabletOlparib · 60 tabletGlenmark Pharmaceuticals · MRP ₹8,054
- ₹166.67/tabletRibaxa Plus · 60 tabletDr. Reddys Laboratories · MRP ₹10,000
- ₹233.25/tabletIbyra · 60 tabletZydus Healthcare · MRP ₹13,995
- ₹251.02/tabletObparp · 8 tabletCipla · MRP ₹2,008
- ₹291.67/tabletLupiparp · 60 tabletLupin · MRP ₹17,500
- ₹294.84/tabletObrenza · 60 tabletSun Pharma Laboratories · MRP ₹17,691
- ₹600.00/tabletBrcaone · 60 tabletEmcure Pharmaceuticals · MRP ₹36,000
9 other brands of this composition on the price list; the 8 lowest per tablet are shown. All Olaparib packs
Olaparib Tablet 150 mg
- ₹218.75/tabletRibaxa · 10 tabletDr. Reddys Laboratories · MRP ₹2,187
- ₹220.54/tabletOlparib · 60 tabletGlenmark Pharmaceuticals · MRP ₹13,232
- ₹233.33/tabletRibaxa Plus · 60 tabletDr. Reddys Laboratories · MRP ₹14,000
- ₹248.44/tabletBracanat · 30 tabletNatco Pharma · MRP ₹7,453
- ₹257.48/tabletIbyra · 60 tabletZydus Healthcare · MRP ₹15,449
- ₹276.12/tabletObparp · 8 tabletCipla · MRP ₹2,209
- ₹335.00/tabletObilix · 60 tabletEris Lifesciences · MRP ₹20,100
- ₹381.25/tabletLupiparp · 60 tabletLupin · MRP ₹22,875
12 other brands of this composition on the price list; the 8 lowest per tablet are shown. All Olaparib packs
The company
Intas Pharmaceuticals has 2,417 packs on the price list, and CDSCO has named it as the manufacturer of 13 failed batches since Sep 2017. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.